CADTH Canadian Drug Expert Committee recommendation (final) Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis

CADTH Canadian Drug Expert Committee recommendation (final) Letermovir (Prevymis -- Merck Canada Inc.) indication cytomegalovirus infection, prophylaxis

Detalles Bibliográficos
Autor principal: Canadian Agency for Drugs and Technologies in Health (author)
Autor Corporativo: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Ottawa (ON) : CADTH 2018.
Materias:
Drug developmen.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820284506719
Descripción
Descripción Física:1 online resource (7 pages)

Ejemplares similares